MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$190,099
Net Income
-$2,628,802
Net Profit Margin
-1382.86%
EPS
-$0.32
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
190,099
119,397
870,542.5*
114,574
Research and development
2,041,389
2,764,394
1,320,619.75*
2,707,777
General and administrative
990,956
1,204,467
1,276,732*
767,837
Total operating expenses
3,032,345
3,968,861
2,597,351.75*
3,475,614
Operating loss
-2,842,246
-3,849,464
-1,726,809.25*
-3,361,040
Interest and investment income
219,851
177,570
184,806.5
174,208
Total other income
219,851
177,570
184,806.5*
174,208
Loss before income tax expense
-2,622,395
-3,671,894
-1,542,002.75*
-3,186,832
Income tax expense
200
-
200*
-
Net loss attributable to common shareholders
-2,622,595
-3,671,894
-1,542,202.75*
-
Net unrealized loss on marketable investment securities
-6,207
-11,639
-1,173.25*
-
Net loss attributable to common shareholders
-
-
-
-3,186,832
Comprehensive loss
-2,628,802
-3,683,533
-1,543,376
-
Basic EPS
-0.32
-0.54
-0.277
-0.59
Diluted EPS
-0.32
-0.54
-0.243
-0.59
Basic Average Shares
8,216,988
6,795,002
5,581,507
5,413,149
Diluted Average Shares
8,216,988
6,795,002
6,359,608
5,413,149
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$2,628,802
Net loss
attributable to common...
-$2,622,595
Net unrealized loss
on marketable...
-$6,207
Interest and investment
income
$219,851
(10.68%↑ Y/Y)
Loss before income
tax expense
-$2,622,395
(-18.89%↓ Y/Y)
Income tax expense
$200
Total other income
$219,851
(10.68%↑ Y/Y)
Operating loss
-$2,842,246
(-18.21%↓ Y/Y)
Total revenues
$190,099
(-69.48%↓ Y/Y)
Total operating
expenses
$3,032,345
(0.17%↑ Y/Y)
Research and development
$2,041,389
(-4.46%↓ Y/Y)
General and
administrative
$990,956
(11.29%↑ Y/Y)
Buy us a coffee
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN)